Yazar "Karadağ, Ömer" için listeleme
-
Do Peripheral and Extra Musculoskeletal Manifestations Have An Impact on Biologic Dmard Prescribing Patterns in Axial Spondyloarthritis: the Results of Treasure Experience
Ediboglu, E. Durak; Solmaz, Duygu; Karadağ, Ömer; Pehlivan, Yavuz; Çınar, M.; Ertenli, Ali İhsan; Akar, Servet; Mercan, Rıdvan (Bmj Publishing Group, 2021)[No Abstract Available] -
The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database
Kanıtez, Nilüfer Alpay; Kiraz, Sedat; Dalkılıç, Ediz; Kimyon, Gezmiş; Mercan, Rıdvan; Karadağ, Ömer; Beş, Cemal; Mercan, Rıdvan (Aves, 2022)Objective: The coronavirus disease 2019 pandemic has been resulting in increased hospital occupancy rates. Rheumatic patients cannot still reach to hospitals, or they hesitate about going to a hospital even they are able ... -
Genotypic characterization of meat-type lambs expressing the callipyge gene in Turkey: I. Carcass characteristics and retail yield
Esen, Vasfiye Kader; Esen, S.; Karadağ, Ömer; Önenç, Alper; Elmacı, C. (TUBITAK, 2022)This study is set out to evaluate the effects of callipyge (CLPG) gene, attributed to sheep affecting growth and meat quality, on carcass and sensory trait of most preferred meat-type lamb (Kivircik, Karacabey Merino, ... -
Short Term Efficacy of Tumor Necrosis Factor Inhibitors in Patients with non-radiographic Axial Spondylarthritis and ankylosing Spondylitis; Results from Turkbio Registry.
Çetin, Pınar; Kalyoncu, Umut; Kisacik, Bunyamin; Sarı, İsmail; Solmaz, Dilek; Karadağ, Ömer; Akkoç, Nurullah (Wiley-Blackwell, 2014)[No Abstract Available] -
Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?
İlgen, Ufuk; Karadağ, Ömer; Emmungil, Hakan; Küçükşahin, Orhan; Koca, Süleyman Serdar; Erden, Abdulsamet; Kalyoncu, Umut; Mercan, Rıdvan (Springer Heidelberg, 2022)This study aimed to compare Tuberculin Skin Test (TST) and QuantiFERON (R)-TB Gold In-Tube (QFT-GIT) test in rheumatoid arthritis (RA) and spondyloarthritis (SpA) patients scheduled for biological and targeted synthetic ...